Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) shares hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $19.50 and last traded at $20.55, with a volume of 1280394 shares trading hands. The stock had previously closed at $21.11.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on SGRY shares. Macquarie lowered their target price on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a research note on Tuesday, March 11th. Royal Bank of Canada reissued an "outperform" rating and set a $35.00 price objective on shares of Surgery Partners in a research report on Tuesday, March 25th. Finally, Bank of America initiated coverage on shares of Surgery Partners in a report on Monday, December 16th. They set a "buy" rating and a $30.00 price objective on the stock. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, Surgery Partners has an average rating of "Moderate Buy" and an average price target of $36.63.
Get Our Latest Analysis on Surgery Partners
Surgery Partners Price Performance
The firm has a market cap of $2.68 billion, a price-to-earnings ratio of -43.73, a PEG ratio of 19.21 and a beta of 2.40. The company's fifty day moving average is $23.99 and its 200 day moving average is $24.76. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99.
Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its quarterly earnings data on Monday, March 3rd. The company reported $0.39 EPS for the quarter, topping analysts' consensus estimates of $0.38 by $0.01. The company had revenue of $864.40 million during the quarter, compared to the consensus estimate of $828.09 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. On average, equities research analysts predict that Surgery Partners, Inc. will post 0.67 EPS for the current year.
Insider Buying and Selling at Surgery Partners
In other Surgery Partners news, CFO David T. Doherty sold 6,733 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $24.02, for a total value of $161,726.66. Following the sale, the chief financial officer now owns 150,868 shares in the company, valued at $3,623,849.36. This represents a 4.27 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Harrison R. Bane sold 56,315 shares of Surgery Partners stock in a transaction that occurred on Friday, February 7th. The stock was sold at an average price of $25.64, for a total value of $1,443,916.60. Following the transaction, the insider now owns 107,037 shares of the company's stock, valued at $2,744,428.68. This represents a 34.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 106,622 shares of company stock worth $2,717,860 over the last ninety days. 2.30% of the stock is currently owned by corporate insiders.
Institutional Trading of Surgery Partners
A number of hedge funds have recently modified their holdings of the stock. KBC Group NV lifted its position in Surgery Partners by 66.1% during the fourth quarter. KBC Group NV now owns 3,962 shares of the company's stock worth $84,000 after acquiring an additional 1,577 shares during the last quarter. State of Wyoming lifted its holdings in Surgery Partners by 94.4% during the 4th quarter. State of Wyoming now owns 4,002 shares of the company's stock worth $85,000 after purchasing an additional 1,943 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. increased its position in Surgery Partners by 12.1% during the 4th quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock worth $91,000 after buying an additional 465 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Surgery Partners by 7,902.7% during the first quarter. GAMMA Investing LLC now owns 8,883 shares of the company's stock worth $211,000 after buying an additional 8,772 shares in the last quarter. Finally, MeadowBrook Investment Advisors LLC lifted its holdings in shares of Surgery Partners by 16.6% during the fourth quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock worth $218,000 after buying an additional 1,460 shares in the last quarter.
About Surgery Partners
(
Get Free Report)
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Recommended Stories
Before you consider Surgery Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surgery Partners wasn't on the list.
While Surgery Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
